NECK PAIN: POSSIBILITY OF TREATMENT
- Authors: KOTOVA O.V.1, AKARACHKOVA E.S.1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Issue: No 2 (2016)
- Pages: 70-75
- Section: Articles
- URL: https://journals.eco-vector.com/2412-4036/article/view/277360
- ID: 277360
Cite item
Open Access
Access granted
Abstract
Neck pain is a common cause of referring the patient to the doctor. The most common type of pain is nonspecific ("mechanical", axial) pain in the neck. The disease may be different, but most patients are completely rid of the disturbing symptoms. For relief of acute back pain most widely used nonsteroidal antiinflammatory drugs. In principle, a new class of drugs for the treatment of pain syndromes, incl neck pain, are selective activators of neuronal potassium channels - SNEPCO (Selective Neuronal Potassium Channel Opener). Representative of this class of drugs is flupirtine (Nolodatak) with a wide range of pharmacological actions. The effectiveness of flupirtine was demonstrated in many randomized controlled trials in which it was compared with other analgesics or placebo. Several studies carried out in patients with degenerative diseases of the spine and myofascial syndrome. In these diseases flupirtine has a pronounced analgesic effect and reduces initially increased muscle tone.
Full Text
About the authors
Olga Vladimirovna KOTOVA
I.M. Sechenov First Moscow State Medical University
Email: ol_kotova@mail.ru
PhD, senior researcher
Elena Sergeevna AKARACHKOVA
I.M. Sechenov First Moscow State Medical UniversityMD, senior researcher
References
- Hoy D.G., Protani M., De R., Buchbinder R. The epidemiology of neck pain. Best Pract. Res. Clin. Rheumatol. 2010;24:783-92.
- Pool J.J., Ostelo R.W., Knol D., Bouter L.M., de Vet H.C. Are psychological factors prognostic indicators of outcome in patients with subacute neck pain? Man. Ther. 2010;15:111-16.
- Barnsley L., Lord S., Bogduk N. Comparative local anaesthetic blocks in the diagnosis of cervical zygapophysial joint pain. Pain. 1993;55:99-106.
- Côté P., van der Velde G., Cassidy J.D., Carroll L.J., HoggJohnson S., Holm L.W., Carragee E.J., Haldeman S., Nordin M., Hurwitz E.L., Guzman J. Peloso P.M. Bone and joint decade 2000-2010 task force on neck pain and its associated disorders. The burden and determinants of neck pain in workers: results of the bone and joint decade 20002010 task force on neck pain and its associated disorders. Spine. (Phila Pa 1976) 2008;33(4 suppl):S60-74.
- De Loose V., Burnotte F., Cagnie B., Stevens V., van Tiggelen D. Prevalence and risk factors of neck pain in military office workers. Mil. Med. 2008;173:474-9.
- Shannon H.S., Woodward C.A., Cunningham C.E., McIntosh J., Lendrum B., Brown J., Rosenbloom D. Changes in general health and musculoskeletal outcomes in the workforce of a hospital undergoing rapid change: A longitudinal study. J. Occup. Health Psychol. 2001;6:3-14.
- Ariens G.A., van Mechelen W., Bongers P.M., Bouter L.M., van der Wal G. Physical risk factors for neck pain. Scand. J. Work Environ. Health. 2000;26:7-19.
- Darivemula S.B., Goswami K., Gupta S.K., Salve H., Singh U., Goswami A.K. Workrelated neck pain among desk job workers of tertiary care hospital in New Delhi, India: burden and determinants. Indian J. Community Med. 2016;41(1) :50-4.
- Côté P., Cassidy J.D., Carroll L.J., Kristman V. The annual incidence and course of neck pain in the general population: a populationbased cohort study. Pain. 2004;1 12(3):267-73.
- Котова О.В., Акарачкова Е.С. Боль в шее: распространенность, факторы возникновения, возможности терапии. Фарматека. 2014;9:45-9
- Guzman J., Haldeman S., Carroll L.J., Carragee E.J., Hurwitz E.L., Peloso P., Nordin M., Cassidy J.D., Holm L.W., Côté P., van der Velde G., HoggJohnson S. Bone and Joint Decade 20002010 Task Force on Neck Pain and Its Associated Disorders Clinical practice implications of the bone and joint decade 20002010 task force on neck pain and its associated disorders: from concepts and findings to recommendations. Spine. (Phila Pa 1976). 2008;33(4 suppl):S199-213.
- Котова О.В., Акарачкова Е.С. Острые болевые синдромы в неврологической практике. Эффективная фармакотерапия. 2014;31:40-5
- Ueberall M., MuellerSchwefe G., Terhaag B. Efficacy and tolerability of flupirtine in subacute / chronic musculoskeletal pain - results of a patient level, pooled reanalysis of randomized, doubleblind, controlled trials. Int. J. Clin. Pharmacol. Ther. 2011;49:637-47.
- Perovic S., Pialoglou P., Schroder H.C., Pergande G., Muller W.E. Flupirtine increases the levels of glutathione and Bc1-2 in hNT (human Ntera/D1) neurons: mode of action of the drugmediated antiapoptotic effect. Eur. J. Pharmacol. 1996;12:157-64.
- Jakob R., Josef Krieglsteinet. Influence of flupirtine on a Gprotein coupled inwardly rectifying potassium current in hippocampal neurons. Br. J. Pharmacol. 1997;122:1333-38.
- Wörz R., MüllerSchwefe G., Stroehmann I., Zeuner L., Zieglgänsberger W., Zimmermann M. Back pain: Guidelines for drug therapy. Fortschr. Med. 2000;142(5):27-33.
- Herrmann W., Hiersemenzel R., Aigner M., Lobisch M., RiethmullerWinzen H., Michel I. Longterm tolerance of flupirtine. Open multicenter study over one year. Fortschr. Med. 1993;111(15):266-70.
- MüllerSchwefe G. Flupertine in acute and chronic pain associated with мuscle tenseness. Results of a postmarketing surveillance study. Forschr. Med. 2003;121:3-10.
- Singal R., Gupta P., Jain N., Gupta S. Role of flupirtine in the treatment of pain- chemistry and its effects. Maedica. (Buchar). 2012;7(2):163-6.
- Котова О.В., Акарачкова Е.С. Место препарата Нолодатака в лечении боли в спине. Фарматека. 2015;13:70-3
Supplementary files
